We show that TREM1 myeloid-derived cytokines IL1 and OSM activate the inflammatory NF-κB family of transcription factors within the BIT tumor epithelium and lower the sensitivity of human BCC explant tumors to SMOi treatment, conferring resistance. The gene discussed is NFKB1; the disease is neoplasm.